Results 321 to 330 of about 189,433 (365)

Current Advances in Mesenchymal Stem Cell Therapies Applied to Wounds and Skin, Eye, and Neuromuscular Diseases in Companion Animals. [PDF]

Animals (Basel)
Picazo RA, Rojo C, Rodriguez-Quiros J, González-Gil A.   +3 more
europepmc   +1 more source

Walking test outcomes in adults with genetic neuromuscular diseases: a systematic literature review of their measurement properties. [PDF]

Eur J Phys Rehabil Med
Hadouiri N, Fournel I, Thauvin-Robinet C, Jacquin-Piques A, Ornetti P, Gueugnon M.   +5 more
europepmc   +1 more source

Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trialP [PDF]

, 2018
et al,, Harms, Matthew, Pestronk, Alan
core   +1 more source

Pre‐symptomatic risdiplam treatment for spinal muscular atrophy initiated at 12 days post‐birth: 14‐month safety and developmental outcomes

Pediatric Investigation, EarlyView.
Zhihao Sun, Liping Wu, Yufan Hui, Yuhang Zhong, Jiangtao Yang, Zhiyong Sun, Xiaoling Huang, Hui Xiong   +7 more
wiley   +1 more source

A Mobile Health App to Support Home-Based Aerobic Exercise in Neuromuscular Diseases: Usability Study.

JMIR Hum Factors
Veneman T, Koopman FS, Oorschot S, Koomen PG, Nollet F, Voorn EL.   +5 more
europepmc   +1 more source

Exercise in Neuromuscular Diseases [PDF]

Physical Medicine and Rehabilitation Clinics of North America, 2012
This article reviews the current knowledge regarding the benefits and contraindications of exercise on individuals with neuromuscular diseases (NMDs). Specific exercise prescriptions for individuals with NMDs do not exist because the evidence base is limited. Understanding the effect of exercise on individuals with NMDs requires the implementation of a
R. Ted Abresch, Jay J. Han, Craig M. McDonald, Gregory T. Carter   +3 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Neuromuscular Diseases

Seminars in Neurology, 2009
Neuromuscular diseases are a broadly defined group of disorders that all involve injury or dysfunction of peripheral nerves or muscle. The site of injury can be in the cell bodies (i.e., amyotrophic lateral sclerosis [ALS] or sensory ganglionopathies), axons (i.e., axonal peripheral neuropathies or brachial plexopathies), Schwann cells (i.e., chronic ...
Brett M. Morrison, John W. Griffin
openaire   +3 more sources

Hypoventilation in Neuromuscular Disease [PDF]

Seminars in Respiratory and Critical Care Medicine, 2009
Hypoventilation in neuromuscular disease is attributed to both respiratory muscle weakness and reduced chemoreceptor sensitivity essential in ventilatory drive. Acute or chronic respiratory failure is seen in a spectrum of neuromuscular disease; whereas some are treatable others are progressive and devastating.
Eric J Huang, Alfredo Vazquez-Sandoval, Shirley F. Jones   +2 more
openaire   +2 more sources

Hereditary neuromuscular diseases

European Journal of Radiology, 2001
This article presents the actual classification of neuromuscular diseases based on present expansion of our knowledge and understanding due to genetic developments. It summarizes the genetic and clinical presentations of each disorder together with CT findings, which we studied in a large group of patients with neuromuscular diseases.
Özsarlak, Ö., Schepens, E., Parizel, Paul M., Van Goethem, Johan, Vanhoenacker, Filip, de Schepper, Arthur, Martin, Jean-Jacques   +6 more
openaire   +4 more sources